The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Retinal Vein Occlusion Treatment Market Projected To Become By 2030 Based On Its 2026 Valuation?
The retinal vein occlusion treatment market has shown strong growth over recent years. It is projected to expand from $2.42 billion in 2025 to $2.59 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.0%. This historical expansion can be attributed to a rise in the incidence of retinal vascular diseases, broader clinical acceptance of anti-VEGF drugs, the proliferation of outpatient ophthalmic services, increased clinical trial activity, and better reimbursement coverage.
The retinal vein occlusion treatment market size is anticipated to undergo significant expansion in the coming years, with projections indicating it will reach $3.37 billion by 2030, progressing at a compound annual growth rate (CAGR) of 6.8%. This growth during the forecast period is propelled by factors such as an escalating demand for enduring treatment outcomes, increased investments in innovative drug delivery systems, the expanding adoption of biosimilars, a heightened emphasis on patient-centric treatment models, and the growing utilization of real-world evidence in therapy selection. Furthermore, major trends characterizing this period include an increasing application of combination drug therapies, the rising uptake of long-acting injectables, greater integration of precision diagnostics, the broadening of personalized treatment protocols, and an enhanced focus on the preservation of visual acuity.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18453&type=smp
Which Market Drivers Are Supporting The Expansion Of The Retinal Vein Occlusion Treatment Market?
The rising occurrence of eye conditions is projected to drive the expansion of the retinal vein occlusion treatment market in the future. Eye conditions encompass any disorders or diseases affecting vision or the eyes. These can range from minor irritations and infections to more severe ailments like glaucoma, cataracts, macular degeneration, and diabetic retinopathy. The increase in eye condition cases is attributed to factors such as aging populations and the growing incidence of diabetes and hypertension. Retinal vein occlusion treatment aims to restore blood flow and reduce inflammation to prevent vision loss and manage complications associated with this eye condition. For instance, in January 2024, the Centers for Disease Control and Prevention, a US-based science and data-driven service organization, reported that over 3.4 million Americans aged 40 years and older were blind or visually impaired, a number expected to double by 2030. Thus, the increasing prevalence of eye conditions is a key factor propelling the growth of the retinal vein occlusion treatment market.
What Segment Groups Are Identified Within The Retinal Vein Occlusion Treatment Market?
The retinal vein occlusion treatment market covered in this report is segmented –
1) By Disease Type: Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO)
2) By Diagnosis: Optical Coherence Tomography, Fundoscopic Examination, Fluorescein Angiography
3) By Treatment: Anti-Vascular Endothelial Growth Factor (Anti-VEGF), Corticosteroid Drugs, Other Treatments
4) By End-User: Hospital And Clinics, Research And Academics, Other End-Users
Subsegments:
1) By Central Retinal Vein Occlusion (CRVO): Non-Ischemic CRVO, Ischemic CRVO
2) By Branch Retinal Vein Occlusion (BRVO): Non-Ischemic BRVO, Ischemic BRVO
What Trends Are Projected To Affect The Retinal Vein Occlusion Treatment Market?
Companies active in the retinal vein occlusion treatment market are concentrating on developing innovative products, such as interchangeable biosimilars, to broaden treatment options and improve patient accessibility. An interchangeable biosimilar is a biologic medicine highly comparable to an existing reference biologic and can serve as an alternative to effectively control inflammation and fluid leakage. For instance, in May 2024, Biocon Biologics Limited, an India-based biosimilar manufacturing company, secured US Food and Drug Administration approval for Yesafili (aflibercept-jbvf), which is an interchangeable biosimilar of EYLEA (aflibercept). It acts as a vascular endothelial growth factor (VEGF) inhibitor, used for treating various ophthalmic conditions like neovascular age-related macular degeneration (wet AMD), macular edema secondary to retinal vein occlusion (branch RVO or central RVO), diabetic macular edema (DME), and myopic choroidal neovascularization (myopic CNV).
Which Companies Hold Significant Positions In The Retinal Vein Occlusion Treatment Market?
Major companies operating in the retinal vein occlusion treatment market are Roche Holding AG, Bayer AG, Novartis International AG, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Santen Pharmaceutical Co Ltd, Chengdu Kanghong Pharmaceutical Group Co Ltd, Genentech Inc, Apellis Pharmaceuticals Inc, Alimera Sciences Inc, Ocular Therapeutix Inc, EyePoint Pharmaceuticals Inc, Aerpio Pharmaceuticals Inc, REGENXBIO Inc, Adverum Biotechnologies Inc, Graybug Vision Inc, Oxurion NV, PanOptica Inc, Clearside Biomedical Inc, Kodiak Sciences Inc, Outlook Therapeutics Inc, Annexin Pharmaceuticals AB
Read the full retinal vein occlusion treatment market report here:
How Is The Retinal Vein Occlusion Treatment Market Distributed Across Key Geographic Regions?
North America was the largest region in the retinal vein occlusion treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal vein occlusion treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Retinal Vein Occlusion Treatment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=18453&type=smp
Browse Through More Reports Similar to the Global Retinal Vein Occlusion Treatment Market 2026, By The Business Research Company
Retinal Vein Occlusion Treatment Global Market Report
Chronic Venous Occlusions Treatment Global Market Report
Vein Illuminator Global Market Report
https://www.thebusinessresearchcompany.com/report/vein-illuminator-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model